BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wu L, Fu J, Wan L, Pan J, Lai S, Zhong J, Chung DC, Wang L. Survival outcomes and surgical intervention of small intestinal neuroendocrine tumors: a population based retrospective study. Oncotarget. 2017;8:4935-4947. [PMID: 27903960 DOI: 10.18632/oncotarget.13632] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Mohamed A, Strosberg JR. Medical Management of Gastroenteropancreatic Neuroendocrine Tumors: Current Strategies and Future Advances. J Nucl Med 2019;60:721-7. [DOI: 10.2967/jnumed.118.214882] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
2 Wright MF, Cates J, Gonzalez RS, Das S, Berlin JD, Shi C. Impact of Peritoneal Metastasis on Survival of Patients With Small Intestinal Neuroendocrine Tumor. Am J Surg Pathol 2019;43:559-63. [PMID: 30702499 DOI: 10.1097/PAS.0000000000001225] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
3 Kelly S, Aalberg J, Agathis A, Phillips K, Haile S, Haines K, Kang Kim M, Divino CM. Predicting Survival of Small Intestine Neuroendocrine Tumors: Experience From a Major Referral Center. Pancreas 2019;48:514-8. [PMID: 30946234 DOI: 10.1097/MPA.0000000000001296] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
4 Michael M, Thursfield V, Te Marvelde L, Kong G, Hicks RJ. Incidence, prevalence, and survival trends for neuroendocrine neoplasms in Victoria, Australia, from 1982 to 2019: Based on site, grade, and region. Asia Pac J Clin Oncol 2021. [PMID: 34821050 DOI: 10.1111/ajco.13671] [Reference Citation Analysis]
5 Shah CP, Mramba LK, Bishnoi R, Unnikrishnan A, Duff JM, Chandana SR. Survival trends of metastatic small intestinal neuroendocrine tumor: a population-based analysis of SEER database. J Gastrointest Oncol 2019;10:869-77. [PMID: 31602324 DOI: 10.21037/jgo.2019.05.02] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
6 Koumarianou A, Alexandraki KI, Wallin G, Kaltsas G, Daskalakis K. Pathogenesis and Clinical Management of Mesenteric Fibrosis in Small Intestinal Neuroendocine Neoplasms: A Systematic Review. J Clin Med. 2020;9. [PMID: 32521677 DOI: 10.3390/jcm9061777] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
7 Xie X, Zhou Z, Song Y, Dang C, Zhang H. Surgical Management and Prognostic Prediction of Adenocarcinoma of Jejunum and Ileum. Sci Rep 2017;7:15163. [PMID: 29123252 DOI: 10.1038/s41598-017-15633-w] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
8 Patanè E, Sgardello SD, Guendil B, Fournier I, Abbassi Z. Unexpected Finding of a Small Intestinal Neuroendocrine Tumor: A Case Report and Literature Review. Am J Case Rep 2020;21:e917759. [PMID: 31988272 DOI: 10.12659/AJCR.917759] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Weber F, Dralle H. Value of ileus-prophylactic surgery for metastatic neuroendocrine midgut tumours. Best Pract Res Clin Endocrinol Metab 2019;33:101342. [PMID: 31628078 DOI: 10.1016/j.beem.2019.101342] [Reference Citation Analysis]
10 Blažević A, Zandee WT, Franssen GJH, Hofland J, van Velthuysen MF, Hofland LJ, Feelders RA, de Herder WW. Mesenteric fibrosis and palliative surgery in small intestinal neuroendocrine tumours. Endocr Relat Cancer 2018;25:245-54. [PMID: 29255095 DOI: 10.1530/ERC-17-0282] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 3.2] [Reference Citation Analysis]
11 Kaemmerer D, Twrznik M, Kulkarni HR, Hörsch D, Sehner S, Baum RP, Hommann M; Center for Neuroendocrine Tumors, Bad Berka – ENETS Center of Excellence. Prior Resection of the Primary Tumor Prolongs Survival After Peptide Receptor Radionuclide Therapy of Advanced Neuroendocrine Neoplasms. Ann Surg 2021;274:e45-53. [PMID: 33030849 DOI: 10.1097/SLA.0000000000003237] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
12 Ricci C, Campana D, Casadei C, Ingaldi C, Ambrosini V, Pagano N, Santini D, Mosconi C, Brighi N, Alberici L, Minni F, Casadei R. A cure model survival analysis of patients affected by small intestinal neuroendocrine neoplasms: the Bologna ENETS center experience. Endocrine 2019;64:702-7. [PMID: 30796689 DOI: 10.1007/s12020-019-01870-8] [Reference Citation Analysis]
13 Fossmark R, Balto TM, Martinsen TC, Grønbech JE, Munkvold B, Mjønes PG, Waldum HL. Hepatic micrometastases outside macrometastases are present in all patients with ileal neuroendocrine primary tumour at the time of liver resection. Scand J Gastroenterol 2019;54:1003-7. [PMID: 31368380 DOI: 10.1080/00365521.2019.1647281] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
14 Daskalakis K, Tsolakis AV. Upfront surgery of small intestinal neuroendocrine tumors. Time to reconsider? World J Gastroenterol 2018; 24(29): 3201-3203 [PMID: 30090001 DOI: 10.3748/wjg.v24.i29.3201] [Reference Citation Analysis]
15 Trikalinos NA, Tan BR, Amin M, Liu J, Govindan R, Morgensztern D. Effect of metastatic site on survival in patients with neuroendocrine neoplasms (NENs). An analysis of SEER data from 2010 to 2014. BMC Endocr Disord 2020;20:44. [PMID: 32245472 DOI: 10.1186/s12902-020-0525-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
16 Tsilimigras DI, Ntanasis-Stathopoulos I, Kostakis ID, Moris D, Schizas D, Cloyd JM, Pawlik TM. Is Resection of Primary Midgut Neuroendocrine Tumors in Patients with Unresectable Metastatic Liver Disease Justified? A Systematic Review and Meta-Analysis. J Gastrointest Surg. 2019;23:1044-1054. [PMID: 30671800 DOI: 10.1007/s11605-018-04094-9] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 7.0] [Reference Citation Analysis]
17 Blažević A, Brabander T, Zandee WT, Hofland J, Franssen GJH, van Velthuysen MF, Feelders RA, De Herder WW. Evolution of the Mesenteric Mass in Small Intestinal Neuroendocrine Tumours. Cancers (Basel) 2021;13:443. [PMID: 33503893 DOI: 10.3390/cancers13030443] [Reference Citation Analysis]